Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Pfizer reported $695M in Interest Expense on Debt for its fiscal quarter ending in September of 2023.

Interest Expense On Debt Change Date
Abbott USD 69M 90M Sep/2023
ALKERMES USD 6.01M 322K Sep/2023
Amgen USD 759M 7M Sep/2023
Biogen USD 63.8M 14.7M Sep/2023
Bristol-Myers Squibb USD 280M 2M Sep/2023
Catalent USD 58M 4M Sep/2023
Eli Lilly USD 124.6M 4.3M Sep/2023
Gilead Sciences USD 232M 2M Sep/2023
Neurocrine Biosciences USD 1.1M 200K Sep/2023
Pacira USD 3.46M 401K Sep/2023
Pfizer USD 695M 187M Sep/2023
Phibro Animal Health USD 5.64M 198K Sep/2023
Prestige Brands USD 17.61M 113K Sep/2023
Regeneron Pharmaceuticals USD 17.8M 1.1M Sep/2023
Roche Holding CHF 401M 53M Jun/2023
Vertex Pharmaceuticals USD 10.9M 300K Sep/2023
Zoetis USD 59M 1000K Sep/2023